Yamina Berchiche
Founder, Chief Executive Officer & Chief Scientific Officer DrGPCR
Yamina Berchiche, PhD, is Founder and Director of Dr. GPCR, a global ecosystem dedicated to advancing GPCR-targeted drug discovery through scientific education, collaboration, and industry engagement. She combines deep expertise in GPCR pharmacology, receptor signaling, and drug discovery with a passion for connecting the global GPCR community. Prior to founding Dr. GPCR, Yamina held leadership roles in biotechnology, including Senior Director of Biology at Superluminal Medicines, where she led GPCR-focused discovery programs. She earned her PhD in Biochemistry from the Université de Montréal, where her research focused on GPCR conformation, signaling, and chemokine receptor biology.
Seminars
- Which modality delivers the greatest advantage across efficacy, safety, tissue penetration and durability, and does the answer depend on the target?
- How much should patient-centric considerations such as dosing frequency, convenience and route of administration influence development decisions?
- When evaluating a new GPCR program, how much does modality choice influence commercial differentiation, partnering opportunities and long-term value creation?
